Delta-like 4 Notch Ligand Regulates Tumor Angiogenesis, Improves Tumor Vascular Function, and Promotes Tumor Growth In vivo
The vascular endothelial growth factor (VEGF) plays a key role in tumor angiogenesis.
However, clinical trials targeting the VEGF pathway are often ineffective, suggesting that …
However, clinical trials targeting the VEGF pathway are often ineffective, suggesting that …
Delta-like 4 Notch Ligand Regulates Tumor Angiogenesis, Improves Tumor Vascular Function, and Promotes Tumor Growth In vivo
JL Li, RCA Sainson, W Shi, R Leek, LS Harrington… - Cancer …, 2007 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: p> The vascular endothelial growth factor (VEGF)
plays a key role in tumor angiogenesis. However, clinical trials targeting the VEGF pathway …
plays a key role in tumor angiogenesis. However, clinical trials targeting the VEGF pathway …
[引用][C] Delta-like 4 Notch Ligand Regulates Tumor Angiogenesis, Improves Tumor Vascular Function, and Promotes Tumor Growth In vivo
JL LI, RCA SAINSON, AL HARRIS… - Cancer research …, 2007 - pascal-francis.inist.fr
Delta-like 4 Notch Ligand Regulates Tumor Angiogenesis, Improves Tumor Vascular
Function, and Promotes Tumor Growth In vivo CNRS Inist Pascal-Francis CNRS Pascal and …
Function, and Promotes Tumor Growth In vivo CNRS Inist Pascal-Francis CNRS Pascal and …
Delta-like 4 Notch ligand regulates tumor angiogenesis, improves tumor vascular function, and promotes tumor growth in vivo
JL Li, RCA Sainson, W Shi, R Leek… - Cancer …, 2007 - pubmed.ncbi.nlm.nih.gov
The vascular endothelial growth factor (VEGF) plays a key role in tumor angiogenesis.
However, clinical trials targeting the VEGF pathway are often ineffective, suggesting that …
However, clinical trials targeting the VEGF pathway are often ineffective, suggesting that …
Delta-like 4 Notch ligand regulates tumor angiogenesis, improves tumor vascular function, and promotes tumor growth in vivo.
JL Li, RC Sainson, W Shi, R Leek, LS Harrington… - Cancer …, 2007 - europepmc.org
The vascular endothelial growth factor (VEGF) plays a key role in tumor angiogenesis.
However, clinical trials targeting the VEGF pathway are often ineffective, suggesting that …
However, clinical trials targeting the VEGF pathway are often ineffective, suggesting that …
[PDF][PDF] Delta-like 4 Notch Ligand Regulates Tumor Angiogenesis, Improves Tumor Vascular Function, and Promotes Tumor Growth In vivo
JL Li, RCA Sainson, W Shi, R Leek, LS Harrington… - academia.edu
The vascular endothelial growth factor (VEGF) plays a key role in tumor angiogenesis.
However, clinical trials targeting the VEGF pathway are often ineffective, suggesting that …
However, clinical trials targeting the VEGF pathway are often ineffective, suggesting that …
[引用][C] Delta-like 4 Notch ligand regulates tumor angiogenesis, improves tumor vascular function, and promotes tumor growth in vivo
JL Li, RCA Sainson, W Shi, R Leek… - Cancer …, 2007 - eprints.ncl.ac.uk
Delta-like 4 Notch ligand regulates tumor angiogenesis, improves tumor vascular function, and
promotes tumor growth in vivo - ePrints - Newcastle University Newcastle University Toggle …
promotes tumor growth in vivo - ePrints - Newcastle University Newcastle University Toggle …
Delta-like 4 Notch ligand regulates tumor angiogenesis, improves tumor vascular function, and promotes tumor growth in vivo.
JL Li, RCA Sainson, W Shi, R Leek, LS Harrington… - 2007 - pearl.plymouth.ac.uk
The vascular endothelial growth factor (VEGF) plays a key role in tumor angiogenesis.
However, clinical trials targeting the VEGF pathway are often ineffective, suggesting that …
However, clinical trials targeting the VEGF pathway are often ineffective, suggesting that …
[PDF][PDF] Delta-like 4 Notch Ligand Regulates Tumor Angiogenesis, Improves Tumor Vascular Function, and Promotes Tumor Growth In vivo
JL Li, RCA Sainson, W Shi, R Leek, LS Harrington… - researchgate.net
The vascular endothelial growth factor (VEGF) plays a key role in tumor angiogenesis.
However, clinical trials targeting the VEGF pathway are often ineffective, suggesting that …
However, clinical trials targeting the VEGF pathway are often ineffective, suggesting that …